Skip to content

Epitope mapping

The evidence-guided identification and resolution of the antigenic site recognized by an antibody, with explicit boundaries among linear, conformational, structural, and functional binding descriptions.

Version
v3 · 2026-09-19 · History
Domain-specific #
1774
Domain group
Natural Sciences
Origin domain
Biology & Ecology
Subdomain
Immunology → Biology & Ecology
Aliases
Antibody epitope mapping, B-cell epitope mapping

Core Idea

Epitope mapping is the evidence-guided determination of which part of an antigen is recognized by a particular antibody or antibody-defined response. The output can range from a broad region to individual residues or a three-dimensional contact surface, and the claimed resolution must match the evidence. Nilvebrant and Rockberg describe mapping as a family of complementary strategies for locating and characterizing antibody-recognition sites rather than as one universal assay. The stable identity is specified binder + specified antigen + evidence about recognition + localized, resolution-qualified site. It is not the antigen itself, not an unverified computational prediction, and not a generic statement that two molecules interact.

How would you explain it like I'm…

Finding the Grab Spot

Your body makes tiny helpers called antibodies that grab onto germs. Each antibody grabs one special spot, like a hand that only fits one handle on a big toy. Epitope mapping is scientists figuring out exactly which handle a certain antibody grabs.

Antibody Target Map

Antibodies are proteins that stick to a target molecule called an antigen, but only at one particular place on it. Epitope mapping means using evidence to find out which part of the antigen a certain antibody recognizes. Sometimes scientists can only say 'somewhere in this area,' and sometimes they can point to exact building blocks. The answer can only be as exact as the evidence allows. Using several different kinds of tests that agree makes the answer stronger.

Locating Antibody Binding Sites

Epitope mapping is working out, from evidence, which part of an antigen a particular antibody recognizes. The answer can be a broad region, specific building blocks (residues) of the protein, or a 3D contact surface, and the precision claimed must match the evidence. Some epitopes are linear, a continuous stretch of the protein chain; others are conformational, made of pieces far apart in the chain that come together when the protein folds. Structural methods can show what physically touches, while functional methods show which changes affect binding without proving direct contact. It is not the same as a computer prediction or just showing that two molecules stick together, and finding an epitope doesn't by itself prove that targeting it would protect someone.

 

Epitope mapping is the evidence-guided localization of the region of an antigen recognized by a specified antibody or antibody-defined response. Its identity is: specified binder, specified antigen, evidence about recognition, and a localized site whose resolution is qualified by that evidence, from a broad region down to individual residues or a 3D contact surface. It is a family of complementary strategies, not one assay. Linear epitopes correspond to contiguous sequence segments (though context can still matter), while conformational or discontinuous epitopes assemble residues distant in primary sequence via folding. Structural evidence describes physical contacts; functional evidence, such as mutational perturbation, identifies residues whose alteration changes binding without proving contact. Agreement across evidence classes strengthens localization, while disagreement may reflect folding, accessibility, allostery, avidity, or assay context. Assays like ELISA supply binding evidence but do not alone localize an epitope, and a mapped epitope is distinct from a claim that targeting it will be protective. Uses include antibody characterization, antigen design, escape interpretation, and grouping antibodies.

Scope of Application

Epitope mapping applies to descriptive characterization of antibody-recognition sites. The abstraction spans evidence classes while requiring that each conclusion remain within the resolution and biological context of the underlying observations.

  • Antibody characterization. Mapped sites distinguish reagents that bind different regions of one antigen.
  • Structural immunology. Contact surfaces can be interpreted in three-dimensional antigen and antibody structures.
  • Diagnostic research. Recognition regions help explain assay specificity and cross-reactivity at a conceptual level.
  • Vaccine research. Mapped sites can inform hypotheses about immune recognition without establishing efficacy by themselves.
  • Escape analysis. Changes associated with reduced binding can be localized and separated from global folding effects.
  • Competition grouping. Overlapping recognition can narrow relationships among antibodies while preserving coarse resolution.
  • Comparative antigen analysis. Conserved and variable regions can contextualize cross-reactivity.
  • Evidence integration. Functional, sequence, competition, and structural observations can jointly constrain a site.

Clarity

Name the antibody or binder, antigen form, species or construct context, and coordinate system used for the mapped site. State whether the claim is regional, sequence-level, residue-level, or atomic. Distinguish continuous sequence evidence from a folded discontinuous surface. Distinguish a structural epitope—physical contacts under a resolved complex—from a functional epitope inferred through changes in binding. A residue whose substitution reduces signal may be a contact, may stabilize the antigen, may alter accessibility, or may change presentation; the inference must reflect those alternatives.

Manages Complexity

Antibody recognition is distributed across sequence, three-dimensional structure, chemical modification, dynamics, and assay context. Epitope mapping organizes this complexity by separating the target pair, the evidence mode, the localization output, and the resolution claim. Sequence-fragment evidence is informative for some continuous sites; structural evidence can reveal a discontinuous surface; functional perturbation can identify important residues while leaving contact status uncertain; competition can establish neighborhood or overlap without exact coordinates.

Abstract Reasoning

  1. Identify the antibody or binder, antigen form, sequence or structure version, and biological context.
  2. State the mapping question and the maximum resolution the evidence class can support.
  3. Classify the candidate site as potentially continuous, conformational, or unresolved.
  4. Separate direct recognition observations from indirect functional or folding effects.
  5. Map evidence onto a declared residue numbering, sequence interval, domain, or structural surface.

Knowledge Transfer

The transferable lesson is that localization depends on the evidence channel and its resolution. A map is not a binary answer but a relation among target, coordinate system, evidence, scale, and uncertainty. That lesson transfers to receptor-site mapping and other molecular characterization, while antibody–antigen recognition remains the domain accent. Measurement is the strict parent because epitope mapping turns observations into a site estimate with resolution, conditions, and uncertainty. The child adds recognition-pair identity, antigen coordinates, conformational structure, functional-versus-structural interpretation, and biological context. Removing those roles yields general localization or measurement.

Relationships to Other Abstractions

Local relationship map for Epitope mappingParents appear above the current abstraction, mutual partners to the right, and children below. Node labels state whether each abstraction is prime or domain-specific; colors identify relation types.Epitope mappingDOMAINPrime abstraction: Measurement — is a kind ofMeasurementPRIME

Current abstraction Epitope mapping Domain-specific

Parents (1) — outgoing typed relations

  • Epitope mapping is a kind of Measurement Prime

    Measurement is the narrowest accepted prime because the workflow maps a binding-site attribute to a region or surface through declared evidence, coordinates, resolution, and uncertainty.

Hierarchy path (1) — routes to 1 parentless root

Neighborhood in Abstraction Space

Epitope mapping sits in a sparse region of the domain-specific corpus (88th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.

Family — Unclustered & Miscellaneous (2769 abstractions)

Nearest neighbors

Computed from structural-signature embeddings · 2026-10-25